 remiss membran glomerulonephr cyclophosphamid prednison object effect cyclophosphamid prednison progress renal failur nephrot featur patient membran glomerulonephr design prospect nonrandom time seri set outpati clinic univers medic center patient eleven consecut patient biopsy-proven membran glomerulonephr plasma creatinin level month intervent cyclophosphamid prednison ten patient patient measur main result ten patient agent median plasma creatinin mumol/l mg/dl month treatment mumol/l mg/dl CI mumol/l combin therapi month median plasma creatinin mumol/l mg/dl median declin mumol/l mg/dl CI mumol/l pretreat plasma creatinin level mumol/l mg/dl ten patient month stabl patient month therapi median urin protein excret g/d month therapi ten patient g/d CI g/d median plasma albumin g/l g/l CI g/l median plasma cholesterol mumol/l mg/dl mumol/l mg/dl CI mumol/l patient relaps month therapi re-treat renal function nephrot variabl normal eleventh patient cyclophosphamid cours similar combin therapi group conclus cyclophosphamid prednison prolong remiss membran glomerulonephr renal function